Glycogen Synthase Kinase (GSK) 3β Phosphorylates and Protects Nuclear Myosin 1c from Proteasome-Mediated Degradation to Activate rDNA Transcription in Early G1 Cells

PLoS Genetics

Volumn 10, Issue 6, 2014, Pages

  Sarshad, Aishe A ^a   Corcoran, Martin ^a   Al Muzzaini, Bader ^a   Borgonovo Brandter, Laura ^a   Von Euler, Anne ^b   Lamont, Douglas ^c   Visa, Neus ^b   Percipalle, Piergiorgio ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; DNA DIRECTED RNA POLYMERASE; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; MYOSIN I; NUCLEAR MYOSIN 1C; PROTEASOME; RIBOSOME DNA; RIBOSOME RNA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; CHROMATIN; F BOX PROTEIN; FBXW8 PROTEIN, HUMAN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; HISTONE; HISTONE ACETYLTRANSFERASE PCAF; MYO1C PROTEIN, HUMAN; P300-CBP-ASSOCIATED FACTOR; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE; UBR5 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE G1 PHASE; CELL ULTRASTRUCTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA TRANSCRIPTION; DOWN REGULATION; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENOME ANALYSIS; HEK293 CELL LINE; HELA CELL LINE; HISTONE ACETYLATION; MOLECULAR DYNAMICS; MOLECULAR STABILITY; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; RNA SYNTHESIS; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION INITIATION; TRANSMISSION ELECTRON MICROSCOPY; UBIQUITINATION; ACETYLATION; ANIMAL; CELL LINE; CHROMATIN; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; PHOSPHORYLATION;

ACETYLATION; ANIMALS; CELL LINE; CHROMATIN; DNA, RIBOSOMAL; F-BOX PROTEINS; G1 PHASE; GLYCOGEN SYNTHASE KINASE 3; HEK293 CELLS; HELA CELLS; HISTONES; HUMANS; MICE; MICE, KNOCKOUT; MYOSIN TYPE I; P300-CBP TRANSCRIPTION FACTORS; PHOSPHORYLATION; PROTEOLYSIS; RNA INTERFERENCE; RNA POLYMERASE I; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ACTIVATION; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84903463163     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004390     Document Type: Article

References (50)

1. Grummt I, (2003) Life on a planet of its own: regulation of RNA polymerase I transcription in the nucleolus. Genes Dev 17: 1691-1702.
2. Moss T, (2004) At the crossroads of growth control: making ribosomal RNA. Curr Opin Genet Dev 14: 210-217.
3. Russell J, Zomerdijk JC, (2006) The RNA polymerase I transcription machinery. Biochem Soc Symp pp. 203-216.
4. de Lanerolle P, Serebryannyy L, (2011) Nuclear actin and myosins: life without filaments. Nat Cell Biol 13: 1282-1288.
5. Visa N, Percipalle P, (2010) Nuclear functions of actin. Cold Spring Harb Perspect Biol 2: a000620.
6. Fomproix N, Percipalle P, (2004) An actin-myosin complex on actively transcribing genes. Exp Cell Res 294: 140-148.
7. Philimonenko VV, Zhao J, Iben S, Dingová H, Kyselá K, et al. (2004) Nuclear actin and myosin I are required for RNA polymerase I transcription. Nat Cell Biol 6: 1165-1171.
8. Ye J, Zhao J, Hoffmann-Rohrer U, Grummt I, (2008) Nuclear myosin 1 acts in concert with polymeric actin to drive RNA polymerase I transcription. Genes Dev 22: 322-330.
9. Sarshad A, Sadeghifar F, Louvet E, Mori R, Böhm S, et al. (2013) Nuclear myosin 1c facilitates the chromatin modifications required to activate rRNA gene transcription and cell cycle progression. PLoS Genet 9: e1003397.
10. Percipalle P, Fomproix N, Cavellán E, Voit R, Reimer G, et al. (2006) The chromatin remodelling complex WSTF-SNF2h interacts with nuclear myosin 1 and has a role in RNA polymerase I transcription. EMBO Rep 7: 525-530.
11. Cavellán E, Asp P, Percipalle P, Östlund-Farrants AK, (2006) The chromatin remodelling complex WSTF-SNF2h interacts with several nuclear proteins in transcription. J Biol Chem 281: 16264-16271.
12. Vintermist A, Böhm S, Sadeghifar F, Louvet E, Mansén A, et al. (2011) The chromatin remodeling complex B-WICH changes the chromatin structure and recruits histone acetyl-transferases to active rRNA genes. PLoS One 6: e19184.
13. Woodgett JR, (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J 9: 2431-2438.
14. Woodgett JR, (1991) cDNA cloning and properties of glycogen synthase kinase-3. Methods Enzymol 200: 564-577.
15. Stambolic V, Woodgett JR, (1994) Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J 303: 701-704.
16. Woodgett JR, (2001) Judging a protein by more than its name: GSK-3. Sci STKE pp. RE12.
17. Wu D, Pan W, (2010) GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem Sci 35: 161-168.
18. Ding VW, Chen RH, McCormick F, (2000) Differential regulation of glycogen synthase kinase 3β by insulin and Wnt signaling. J Biol Chem 275: 32475-32481.
19. Welcker M, Orian A, Jin J, Grim JE, Harper JW, et al. (2004) The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci USA 101: 9085-9090.
20. Ryves WJ, Harwood AJ, (2003) The interaction of glycogen synthase kinase-3 (GSK-3) with the cell cycle. Prog Cell Cycle Res 5: 489-495.
21. Grisouard J, Medunjanin S, Hermani A, Shukla A, Mayer D, (2007) Glycogen Synthase Kinase-3 Protects Estrogen Receptor from Proteasomal Degradation and Is Required for Full Transcriptional Activity of the Receptor. Mol Endocrinology 21: 2427-2439.
22. Drygin D, Rice WG, Grummt I, (2010) The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer. Annu Rev Pharmacol Toxicol 50: 131-156.
23. Liu M, Tu X, Ferrari-Amorotti G, Calabretta B, Baserga R, (2007) Downregulation of the upstream binding factor1 by glycogen synthase kinase3beta in myeloid cells induced to differentiate. J Cell Biochem 100: 1154-1169.
24. Vincent T, Kukalev A, Andäng M, Pettersson R, Percipalle P, (2008) The glycogen synthase kinase (GSK) 3beta represses RNA polymerase I transcription. Oncogene 27: 5254-5259.
25. Al-Khouri AM, Ma Y, Togo SH, Williams S, Mustelin T, (2005) Cooperative phosphorylation of the tumour suppressor phopsphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3b. J Biol Chem 280: 35195-35196.
26. O'Sullivan AC, Sullivan GJ, McStay B, (2002) UBF binding in vivo is not restricted to regulatory sequences within the vertebrate ribosomal DNA repeat. Mol Cell Biol 22: 657-658.
27. Sanij E, Poortinga G, Sharkey K, Hung S, Holloway TP, et al. (2008) UBF levels determine the number of active ribosomal RNA genes in mammals. J Cell Biol 183: 1259-1274.
28. Zentner GE, Saiakhova A, Manaenkov P, Adams MD, Scacheri PC, (2011) Integrative genomic analysis of human ribosomal DNA. Nucleic Acids Res 39: 4949-4960.
29. Percipalle P, Louvet E, (2012) In vivo run-on assays to monitor nascent precursor RNA transcripts. Methods Mol Biol 809: 519-533.
30. Mohn F, Weber M, Schübeler D, Roloff TC, (2009) Methylated DNA immunoprecipitation (MeDIP). Methods Mol Biol 507: 55-64.
31. Sérandour AA, Avner S, Percevault F, Demay F, Bizot M, et al. (2011) Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. Genome Res 21: 555-565.
32. Boulon S, Westman BJ, Hutten S, Boisvert FM, Lamond AI, (2010) The nucleolus under stress. Mol Cell 40: 216-227.
33. Taelman VF, Dobrowolski R, Plouhinec JL, Fuentealba LC, Vorwald PP, et al. (2010) Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 143: 1136-1148.
34. Kinoshita E, Kinoshita-Kikuta E, Ujihara H, Koike T, (2009) Mobility shift detection of phosphorylation on large proteins using a Phos-tag SDS-PAGE gel strengthened with agarose. Proteomics 9: 4098-4101.
35. Rosner M, Schipany K, Hengstschläger M, (2013) Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle. Nat Protoc 8: 602-626.
36. Cole A, Frame S, Cohen P, (2004) Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK) in mammalian cells is an autophosphorylation event. Biochem J 377: 249-255.
37. Meijer L, Skaltsounis AL, Magiatis P, Polychronopoulos P, Knockaert M, et al. (2003) GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem Biol 10: 1255-1266.
38. Tseng A-S, Engel FB, Keating MT, (2006) The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes. Chem Biol 13: 957-963.
39. Jope RS, Johnson GVW, (2004) The glamour and gloom of glycogen synthase-3. Trends Biochem Sci 29: 95-102.
40. Fiol CJ, Mahrenholz AM, Wang Y, Roeske RW, Roach PJ, (1987) Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3. J Biol Chem 262: 14042-14048.
41. Cohen P, Frame S, (2001) The renaissance of GSK3. Nat Rev Mol Cell Biol 2: 769-776.
42. Fuentealba LC, Eivers E, Ikeda A, Hurtado C, Kuroda H, et al. (2007) Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 131: 980-993.
43. Kim NG, Xu C, Gumbiner BM, (2009) Identification of targets of the Wnt pathway destruction complex in addition to β-catenin. Proc Natl Acad Sci USA 106: 5165-5170.
44. Hay-Koren A, Caspi M, Rosin-Arbesfeld R, (2011) The EDD E3 ligase ubiquitinates and up-regulates beta-catenin. Mol Biol Cell 22: 399-411.
45. Tasaki T, Sriram SM, Park KS, Kwon YT, (2012) The N-end rule pathway. Annu Rev Biochem 81: 261-289.
46. Tsai YC, Greco TM, Boonmee A, Miteva Y, Cristea IM, (2012) Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription. Mol Cell Proteomics 11: 60-76.
47. Munoz MA, Saunders DN, Henderson MJ, Clancy JL, Russell AJ, et al. (2007) The E3 ubiquitin ligase EDD regulates S-phase and G(2)/M DNA damage checkpoints. Cell Cycle 6: 3070-3077.
48. Smits VA, (2012) EDD induces cell cycle arrest by increasing p53 levels. Cell Cycle 11: 715-720.
49. Benavides M, Chow-Tsang LF, Zhang J, Zhong H, (2013) The novel interaction between microspherule protein Msp58 and ubiquitin E3 ligase EDD regulates cell cycle progression. Biochim Biophys Acta 1833: 21-32.
50. Young DW, Hassan MQ, Pratap J, Galindo M, Zaidi SK, et al. (2007) Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2. Nature 445: 442-446.